Cargando…

Tu1552: PRESERVED SARS-COV-2 VACCINE CELL-MEDIATED IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNEMODULATING THERAPIES

Detalles Bibliográficos
Autores principales:	Boland, Brigid S., Goodwin, Benjamin, Zhang, Zeli, bloom, Nathaniel, Neill, Jennifer, Le, Helen, Collins, Angelina, Dulai, Parambir, Singh, Siddharth, Nguyen, Nghia H., Grifoni, Alba, Weiskopf, Daniella, Chang, John T., Dan, Jennifer M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212360/ http://dx.doi.org/10.1016/S0016-5085(22)62390-4

Ejemplares similares

Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies
por: Boland, Brigid S., et al.
Publicado: (2022)

Tu1554: A NOVEL METHOD FOR COLLECTING MICROBIOME SPECIMENS
por: Rahimian, Pejman, et al.
Publicado: (2022)

Fr001 PROTON PUMP INHIBITOR AND RISK OF SARS-COV-2 INFECTION: A MULTI-CENTER EXPERIENCE
por: Silverman, Anna L., et al.
Publicado: (2021)

Tu1544: HUMORAL AND T CELL RESPONSES TO COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022)

Tu1110: EXPRESSION OF EPITHELIAL PROTEASES PREDICTS SARS-COV-2 ENTRY IN HUMAN ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2022)

Tu1041: EFFECT OF TIMING PROTOCOL ON AFTER-HOURS ENDOSCOPY FOR FOREIGN BODY INGESTIONS AND ESOPHAGEAL IMPACTIONS
por: Karb, Daniel B., et al.
Publicado: (2022)

Tu1547: COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Meybodi, Mohamad Aghaie, et al.
Publicado: (2022)

Tu1033: IMPACT OF GERD ON PATIENTS UNDERGOING LUNG TRANSPLANTION FOR COVID-19: A SINGLE INSTITUTION RETROSPECTIVE STUDY
por: Kim, Christopher, et al.
Publicado: (2022)

Tu1108: INTERVAL CANCERS IN PATIENTS WITH HEREDITARY GASTROINTESTINAL SYNDROMES AFTER ONE YEAR OF THE SARS-COV-2 PANDEMIC
por: Barchi, Alberto, et al.
Publicado: (2022)

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Tu1553: SPECIFIC IMMUNOGLOBLIN A INDUCED BY THE PERSISTENT COLONIZATION OF ADHERENT-INVASIVE E.COLI LIMITS PATHOBINT LOCALIZATION TO THE EPITHELIAL NICHE
por: Imai, Jin, et al.
Publicado: (2022)

Tu1040: COMPARATIVE EFFECTIVENESS OF VIRTUAL VS. IN-PERSON VISITS IN THE INITIAL EVALUATION OF ABDOMINAL PAIN PRIOR TO AND DURING THE COVID-19 PANDEMIC.
por: Sasankan, Priya, et al.
Publicado: (2022)

Tu1548: IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY
por: Dayam, R.M., et al.
Publicado: (2022)

Tu1549: IMPLEMENTATION AND SHORT-TERM ADVERSE EVENTS OF ANTI-SARSCOV-2 VACCINES IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTERNATIONAL WEB-BASED SURVEY
por: Revés, Joana, et al.
Publicado: (2022)

Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES
por: Watanabe, Kenji, et al.
Publicado: (2022)

Tu1109: ENDOTHELIAL CELLS AND BLOOD VESSELS – CRITICAL TARGETS FOR COVID-19-INDUCED TISSUE INJURY AND SPREAD TO DISTANT ORGANS. UNDERLYING MECHANISMS INCLUDE ENDOTHELIAL DYSFUNCTION AND INJURY
por: Ahluwalia, Amrita, et al.
Publicado: (2022)

Sa503 MACHINE LEARNING OUTPERFORMS TRADITIONAL RISK MODEL IN IDENTIFYING HIGH-NEED, HIGH-COST PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN A NATIONALLY REPRESENTATIVE COHORT
por: Nguyen, Nghia H., et al.
Publicado: (2021)

Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB
por: Spalinger, Marianne, et al.
Publicado: (2021)

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
por: Zacharopoulou, Eirini, et al.
Publicado: (2022)

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease
por: Holmer, Ariela K., et al.
Publicado: (2020)

Senate Bill No. 1552
Publicado: (1896)

Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Schell, Trevor, et al.
Publicado: (2022)

Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY
por: Joergensen, Kristin K., et al.
Publicado: (2022)

Defeat Senate Bill 1552
Publicado: (1896)

Fr499 RATES OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES INFECTION DURING THE COVID-19 PANDEMIC IN A TERTIARY HEALTHCARE SETTING
por: Hazel, Karl, et al.
Publicado: (2021)

252 PREDNISONE, BUT NOT BIOLOGICS OR IMMUNOMODULATORS ARE ASSOCIATED WITH SEVERE COVID-19 OUTCOMES: A COMMUNITY BASED STUDY
por: Velayos, Fernando, et al.
Publicado: (2021)

Mo1019: THE IMPACT OF IBS ON SELF-REPORTED PHYSICAL AND MENTAL HEALTH DURING THE COVID PANDEMIC – A NORWEGIAN TWIN STUDY
por: Kutschke, Julia, et al.
Publicado: (2022)

Improving Colorectal Cancer Screening and Polyp Surveillance During the COVID-19 Pandemic
por: Mujtaba, Sobia, et al.
Publicado: (2021)

Sa1056: RAPID IMPLEMENTATION OF AN EVIDENCE-BASED, VIRTUAL COVID-19 VACCINE EDUCATION CLINIC AT THE NOVA SCOTIA COLLABORATIVE INFLAMMATORY BOWEL DISEASE CLINIC (NSCIBD)
por: Komeylian, Hamed, et al.
Publicado: (2022)

Su1187 ALMOST EVERYTHING CAUSES DIARRHEA: GASTROINTESTINAL MANIFESTATIONS OF ACUTE RESPIRATORY INFECTIONS AMONG 3,510 INDIVIDUALS IN A COMMUNITY-BASED STUDY
por: Newman, Kira L., et al.
Publicado: (2020)

AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update
por: Sultan, Shahnaz, et al.
Publicado: (2021)

656: POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Mujukian, Angela, et al.
Publicado: (2022)

653: PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION
por: Li, Dalin, et al.
Publicado: (2022)

Poster 1026: Randomized clinical trial to evaluate oral dializable leukocyte extracts as immunemodulator treatment in atopic dermatitis
por: García, Alejandro Estrada, et al.
Publicado: (2014)

Su1492: STRONG HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE ADDITIONAL DOSE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES
por: Kappelman, Michael, et al.
Publicado: (2022)

Rodolfo II de Habsburgo, 1552-1612 : el emperador insólito
por: Erlanger, Philippe, 1903-1987

AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_66ukmarh2l73a3190r9rda6isa